Your browser doesn't support javascript.
loading
[Recommendations for the medication of rheumatic diseases in periconceptional period].
Zhang, W; Li, Y S; Liu, D Z; Li, J; Su, J; Wang, L; Zhang, Z L; Zuo, X X; Zhao, Yan.
Afiliação
  • Zhang W; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, State Key Laboratory of Com
  • Li YS; Department of Rheumatology and Immunology, Xiangya Hospital, Central South University, Changsha 410008, China.
  • Liu DZ; Department of Rheumatology and Immunology, Shenzhen People's Hospital, the Second Clinical Medical College, Jinan University, Shenzhen 518020, China.
  • Li J; Department of Rheumatic & TCM Medical Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
  • Su J; Department of Rheumatology and Immunology, Qinghai University Affiliated Hospital, Xining 810001, China.
  • Wang L; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, State Key Laboratory of Com
  • Zhang ZL; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing 100034, China.
  • Zuo XX; Department of Rheumatology and Immunology, Xiangya Hospital, Central South University, Changsha 410008, China.
  • Zhao Y; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, State Key Laboratory of Com
Zhonghua Nei Ke Za Zhi ; 60(11): 946-953, 2021 Nov 01.
Article em Zh | MEDLINE | ID: mdl-34689514
ABSTRACT
Rheumatic diseases are a kind of chronic inflammatory diseases mainly involving joints and surrounding tissues. Most patients with rheumatic diseases need long-term treatment, which is difficult to be avoided during pregnancy. Treatment efficacy, as well as maternal and fetal safety should be taken into account in the medical decision. Based on the domestic and foreign guidelines, consensus, diagnosis and treatment experience, Chinese Rheumatology Association developed the standardization of medication use in patients with rheumatic diseases preparing and during pregnancy, aiming on the application and precautions of commonly used medicines for rheumatic diseases in preparing pregnancy, pregnancy and lactation.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reumatologia / Doenças Reumáticas Idioma: Zh Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reumatologia / Doenças Reumáticas Idioma: Zh Ano de publicação: 2021 Tipo de documento: Article